G9843 – Ras (kras or nras) gene mutation

Long description

Ras (kras or nras) gene mutation

Short description

Kras or nras gene mutation

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2017

Last change

January 1, 2018 – No change

Nearby G codes

• G9835 – Trastuzumab administered within 12 months of diagnosis
• G9836 – Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)
• G9837 – Trastuzumab not administered within 12 months of diagnosis
• G9838 – Patient has metastatic disease at diagnosis
• G9839 – Anti-egfr monoclonal antibody therapy
• G9840 – Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab
• G9841 – Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab
• G9842 – Patient has metastatic disease at diagnosis
• G9844 – Patient did not receive anti-egfr monoclonal antibody therapy
• G9845 – Patient received anti-egfr monoclonal antibody therapy
• G9846 – Patients who died from cancer
• G9847 – Patient received systemic cancer-directed therapy in the last 14 days of life
• G9848 – Patient did not receive systemic cancer-directed therapy in the last 14 days of life
• G9849 – Patients who died from cancer
• G9850 – Patient had more than one emergency department visit in the last 30 days of life
• G9851 – Patient had one or less emergency department visits in the last 30 days of life